Does CYTARABINE Cause Neoplasm recurrence? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Neoplasm recurrence have been filed in association with CYTARABINE (cytarabine). This represents 0.5% of all adverse event reports for CYTARABINE.
223
Reports of Neoplasm recurrence with CYTARABINE
0.5%
of all CYTARABINE reports
38
Deaths
32
Hospitalizations
How Dangerous Is Neoplasm recurrence From CYTARABINE?
Of the 223 reports, 38 (17.0%) resulted in death, 32 (14.3%) required hospitalization, and 6 (2.7%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
DEXAMETHASONE (135)
Which CYTARABINE Alternatives Have Lower Neoplasm recurrence Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB